Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa

por Butros, Linda, Boayue, Koh, Mathew, Prasad
Publicado 2011

Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial

por Morfini, Massimo, Guarnieri, Chiara, Macchia, Roberta, Scarpellini, Manuela, Mathew, Prasad
Publicado 2020

Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies

por Humphries, Thomas J., Rauchensteiner, Stephan, Tückmantel, Claudia, Pieper, Alexander, Maas Enriquez, Monika, Mathew, Prasad
Publicado 2015

Kikuchi-Fujimoto Disease: Clinical and Laboratory Characteristics and Outcome

por Rakesh, PS, Alex, Reginald G, Varghese, George M, Mathew, Prasad, David, Thambu, Manipadam, Marie Therese, Nair, Sheila, Abraham, Ooriapadickal Cherian
Publicado 2014

Prophylaxis and hemophilia care in LATAM: Baring it all—Highlights from the CLAHT 2021 symposium

por DiMinno, Giovanni G., Araujo Cabrera, Lida Milena, Loayza Urcia, Nancy, Bordone, Raul, Murillo, Carlos Martinez, Beltran, Juan Carlos, Mathew, Prasad
Publicado 2022

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study

por Wu, Runhui, Li, Xiaojing, Yao, Wanru, Zhang, Qing, Zhou, Min, Zhang, Ningning, Yang, Sheng, Chen, Zhenping, Wang, Yan, Kuang, Yangying, Tang, Ling, Zhen, Yingzi, Abad, Audrey, Doria, Andrea S., Hilliard, Pamela, Ignas, Danial M., Mathew, Prasad, Stephens, Derek, Blanchette, Victor S., Luke, Koon‐Hung
Publicado 2021